Comparative assessment of18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 8, 2006, Pages 879-886

  Shirasaki, Haruhisa ^a   Nakano, Akira ^a   Uzui, Hiroyasu ^a   Yonekura, Yoshiharu ^a   Okazawa, Hidehiko ^a   Ueda, Takanori ^a   Lee, Jong Dae ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

18F fluorodeoxyglucose; 99mTc tetrofosmin; Myocardial viability; Reperfused myocardium

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; CONVALESCENCE; DRUG SENSITIVITY; DRUG SPECIFICITY; DRUG UPTAKE; FEMALE; FUNCTIONAL ASSESSMENT; GENERAL CONDITION IMPROVEMENT; GLUCOSE METABOLISM; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REPERFUSION; HEART PRESERVATION; HEART VENTRICLE WALL MOTION; HEART VENTRICULOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MALE; POPULATION RESEARCH; POSITRON EMISSION TOMOGRAPHY; PREDICTION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; METHODOLOGY; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY; SCINTISCANNING; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RECOVERY OF FUNCTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33746502475     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0071-0     Document Type: Article

References (26)

1. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60
2. Segall G. Assessment of myocardial viability by positron emission tomography.Nucl Med Commun 2002;23:323-30
3. 18F-fluoro-deoxyglucose positron emission tomography for the detection of myocardial viability. Eur Heart J 2001;22:1691-701
4. vom Dahl J, Eitzman DT, al-Aouar ZR, Kanter HL, Hicks RJ, Deeb GM, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-66
5. vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Uebis R, Messmer BJ, et al. Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol 1996;28:948-58
6. Schwaiger M, Brunken R, Grover-McKay M, Krivokapich J, Child J, Tillisch JH, et al. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positoron emission tomography. J Am Coll Cardiol 1986;8:800-8
7. Maes A, Van de Werf F, Nuyts J, Bormans G, Desmet W, Mortelmans L. Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up. Circulation 1995;92:2072-8
8. Maes A, Mortelmans L, Nuyts J, Bormans G, Herregods MC, Bijnens B, et al. Importance of flow/metabolism studies in predicting late recovery of function following reperfusion in patients with acute myocardial infarction. Eur Heart J 1997;18:954-62
9. Rubin PJ, Lee DS, Davila-Roman VG, Geltman EM, Schechtman KB, Bergmann SR, et al. Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction. Am J Cardiol 1996;78:1230-5
10. Maes AF, Van de Werf F, Mesotten LV, Flamen PB, Kuzo RS, Nuyts JL, et al. Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate. J Am Coll Cardiol 2001;37:30-6
11. Kurihara H, Nakamura S, Hatada K, Takehana K, Hamada S, Watanabe J, et al. Early prediction of regional functional recovery in reperfused myocardium using single-injection resting quantitative electrocardiographic gated SPET. Eur J Nucl Med Mol Imaging 2002;29:458-64
12. Sugihara H, Nakagawa T, Yamashita E, Kinoshita N, Ito K, Azuma A, et al. Reverse redistribution of Tc-99m-tetrofosmin in patients with acute myocardial infarction. Ann Nucl Med 1999;13:43-7
13. Metz CE, Herman BA, Roe CA. Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets. Med Decis Making 1998;18:110-21
14. Tani T, Teragaki M, Watanabe H, Muro T, Yamagishi H, Akioka K, et al. Detecting viable myocardium and predicting functional improvement: comparisons of positron emission tomography, rest-redistribution thallium-201 single-photon emission computed tomography (SPECT), exercise thallium-201 reinjection SPECT, I-123 BMIPP SPECT and dobutamine stress echocardiography. Circ J 2004;68:950-7
15. Wijns W, Melin JA, Leners N, Ferrant A, Keyeux A, Rahier J, et al. Accumulation of polymorphonuclear leukocytes in reperfused ischemic canine myocardium: relation with tissue viability assessed by fluorine-18-2- deoxyglucose uptake. J Nucl Med 1988;29:1826-32
16. Perrone-Filardi P, Bacharach SL, Dilsizian V, Marin-Neto JA, Maurea S, Arrighi JA, et al. Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:608-16
17. Mesotten L, Maes A, Herregods MC, Desmet W, Nuyts J, Van de Werf F, et al. PET "reversed mismatch pattern" early after acute myocardial infarction: follow-up of flow, metabolism and function. Eur J Nucl Med 2001;28:466-71
18. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002;39:591-7
19. Schwaiger M, Neese RA, Araujo L, Wyns W, Wisneski JA, Sochor H, et al. Sustained nonoxidative glucose utilization and depletion of glycogen in reperfused canine myocardium. J Am Coll Cardiol 1989;13:745-54
20. Buxton DB, Schelbert HR. Measurement of regional glucose metabolic rates in reperfused myocardium. Am J Physiol 1991;261:H2058-68
21. Buxton DB, Mody FV, Krivokapich J, Phelps ME, Schelbert HR. Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium. Circulation 1992;85:1842-56
22. Sebree L, Bianco JA, Subramanian R, Wilson MA, Swanson D, Hegge J et al. Discordance between accumulation of C-14 deoxyglucose and Tl-201 in reperfused myocardium. J Mol Cell Cardiol 1991;23:603-16
23. Myears DW, Sobel BE, Bergmann SR. Substrate use in ischemic and reperfused canine myocardium: quantitative considerations. Am J Physiol 1987;253:H107-14
24. 99mTc-tetrofosmin SPECT in patients with acute myocardial infarction. J Nucl Med 2001;42:1351-8
25. Ng CK, Soufer R, McNulty PH. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake. J Nucl Med 1998;39:379-83
26. He W, Acampa W, Mainolfi C, Menna F, Sorrentino AR, Petretta M, et al. Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET. J Nucl Cardiol 2003;10:599-606